DexCom Inc

18 sept. 2026, 20:07 UTC

Dexcom Inc shares are advancing as Truist Securities raised its price target to $102 and TD Cowen reiterated its Buy rating with a $95 target.

17 sept. 2026, 19:26 UTC

Dexcom's stock is higher as Truist Securities raises its price target to $102.00 from $93.00, maintaining a Buy rating.

16 sept. 2026, 20:10 UTC

Dexcom Inc is trading higher, reaching a peak in late morning and settling above Tuesday's close, marking three consecutive daily gains.

15 sept. 2026, 20:01 UTC

Dexcom Inc shares are trading higher amid broader market concerns following a significant decline in the NY Empire State Manufacturing Index.

10 sept. 2026, 19:36 UTC

Dexcom Inc shares are higher in Thursday's session, recovering from an initial dip. The stock remains below its 20-day moving average. No specific news identified.

9 sept. 2026, 22:11 UTC

Dexcom Inc shares are higher in after-market trading, reflecting a positive shift since Wednesday's close, despite recent lower closes and no specific news.

8 sept. 2026, 20:01 UTC

Dexcom Inc. shares are lower today, trading significantly below their 20-day moving average amid speculation of a potential Federal Reserve interest rate hike.

28 aug. 2026, 20:08 UTC

Dexcom Inc shares are higher today, aligning with a broader market increase. The asset is trading above its 20-day moving average.

26 aug. 2026, 19:16 UTC

Dexcom Inc's shares are higher today, reaching their peak around 14:50 ET. The stock remains above its 20-day moving average.

25 aug. 2026, 20:07 UTC

Dexcom Inc. shares are lower today amid broader market weakness. The stock remains above its 20-day moving average despite recent declines since Monday's close.

21 aug. 2026, 19:36 UTC

Dexcom Inc shares are higher as $1.6 million in call options signals bullish investor sentiment. The stock has recovered from earlier session lows.

20 aug. 2026, 19:36 UTC

Dexcom Inc shares are higher today, continuing a three-session upward trend. The stock has fluctuated within a narrow range during regular trading hours.

19 aug. 2026, 19:41 UTC

Dexcom Inc shares are higher Wednesday, pulling back from an early peak. The stock is trading with unusually high volume and remains above its 20-day moving average.

18 aug. 2026, 19:16 UTC

Dexcom Inc shares are higher today, reflecting positive market sentiment despite no specific news. The stock remains above its 20-day moving average.

17 aug. 2026, 19:46 UTC

Dexcom Inc's shares are lower today, continuing a decline since Friday's close. No specific news has been identified to explain the price movement.

14 aug. 2026, 19:16 UTC

Dexcom Inc shares are lower today, continuing a decline since Thursday's close amid broader market caution following an unexpected drop in U.S. retail sales.

13 aug. 2026, 19:26 UTC

Dexcom Inc shares are higher today, despite an earlier pullback. The stock's advance contrasts with a broader market decline since the session's start.

12 aug. 2026, 19:36 UTC

Dexcom Inc shares are higher amid broader market optimism following inflation data. The core Consumer Price Index showed a modest increase, aligning with forecasts.

11 aug. 2026, 23:26 UTC

Dexcom Inc shares are trading lower in after-market hours. Broader market trends and cautious investor sentiment may be influencing this price movement.

10 aug. 2026, 20:02 UTC

Dexcom Inc shares are higher today, continuing an upward trend since Friday. The move occurs amid recent labor market data influencing investor sentiment.

7 aug. 2026, 23:46 UTC

Dexcom Inc shares are higher in after-market hours, continuing recent positive momentum. The stock remains well above its 20-day moving average.

5 aug. 2026, 19:51 UTC

Dexcom shares are declining amid negative sentiment in the insulin sector following Podd's revenue growth forecast cut. Broader economic data also influences cautious market sentiment.

4 aug. 2026, 19:56 UTC

Dexcom Inc. shares are lower today, pulling back after reaching a session high. The broader market benefits from a significant decline in crude oil prices.

3 aug. 2026, 20:02 UTC

Dexcom Inc. shares are higher following strong Q2 results and raised revenue guidance to $5.22 billion. Canaccord increased its price target to $90.

31 iul. 2026, 20:04 UTC

Dexcom Inc. shares are higher following analyst upgrades and strong earnings, with second-quarter revenue of $1.31 billion exceeding expectations and guidance raised to $5.22 billion.

30 iul. 2026, 23:51 UTC

Dexcom reported second-quarter revenue of $1.308 billion and adjusted EPS of $0.70, raising its fiscal year 2026 revenue guidance, with shares trading higher in after-market hours.

29 iul. 2026, 23:41 UTC

Dexcom Inc is trading higher in after-market hours, supported by overall market strength. The asset remains above its 20-day moving average.

28 iul. 2026, 20:06 UTC

Dexcom shares rise after UBS initiated coverage with a Buy rating. The stock is advancing since Monday's close of $73.37 amid positive sentiment in the Health Care Equipment sector.

27 iul. 2026, 19:06 UTC

Dexcom Inc. gains Health Canada approval for its Dexcom G7 continuous glucose monitoring system, boosting marketability and user adoption amid positive analyst sentiment.

24 iul. 2026, 15:22 UTC

Dexcom Inc's shares are higher today, driven by gains in the Health Care Equipment sub-sector. No specific company news was identified for the movement.